Is migraine in the elderly a distinct entity? A comparative cross-sectional study
Abstract
BACKGROUND AND OBJECTIVES
The clinical characteristics, disability, and comorbidities of migraine are not well characterized in the elderly, especially in comparison with the young. We aimed to study the headache characteristics, treatment profile, disability, and pattern of comorbidities in the elderly patients with migraine and compare these with those of younger patients with migraine to see if migraine in the elderly differs significantly from that in the young.
METHODS
We conducted a comparative cross-sectional hospital-based study of patients (n = 154) with migraine, aged 60 years and above (n = 81), and between the ages of 20 and 40 years (n = 73). In addition to the demographic and clinical details, patients were also evaluated with Migraine disability assessment questionnaire for disability and the Visual Analogue Scale for severity of headache. We also assessed anxiety, depression, and sleep quality.
RESULTS
Women constituted the majority of the elderly and young age groups. Migraine was less throbbing (p < 0.001), more likely to be holocranial (p = 0.009), more frequent (p = 0.043), less severe (p=<0.001), less likely to be associated with vomiting (p = 0.003), less disabling (p=<0.001) in the elderly as compared to the young. The prevalence of medication overuse headache (p = 0.014), depression (p = 0.004), and poor sleep quality (p = 0.001) was higher in the elderly with migraine group.
CONCLUSION
The migraine in the elderly, though more frequent than that in…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 154 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.